Labcorp
785 hedge funds and large institutions have $17B invested in Labcorp in 2018 Q2 according to their latest regulatory filings, with 62 funds opening new positions, 279 increasing their positions, 302 reducing their positions, and 61 closing their positions.
143% more call options, than puts
Call options by funds: $64.5M | Put options by funds: $26.6M
36% more funds holding in top 10
Funds holding in top 10: 14 → 19 (+5)
11% more capital invested
Capital invested by funds: $15.4B → $17B (+$1.63B)
2% more first-time investments, than exits
New positions opened: 62 | Existing positions closed: 61
1% less funds holding
Funds holding: 791 → 785 (-6)
0.82% less ownership
Funds ownership: 108.84% → 108.02% (-0.82%)
8% less repeat investments, than reductions
Existing positions increased: 279 | Existing positions reduced: 302
Top Buyers
| 1 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$228M |
| 2 |
O
OppenheimerFunds
New York
|
+$159M |
| 3 |
ECU
Egerton Capital (UK)
London,
United Kingdom
|
+$148M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$132M |
| 5 |
BlackRock
New York
|
+$128M |
Top Sellers
| 1 |
GCM
Glenview Capital Management
New York
|
-$237M |
| 2 |
Goldman Sachs
New York
|
-$125M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$97.5M |
| 4 |
Renaissance Technologies
New York
|
-$62.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$50.1M |
LH Hedge Fund Activity: Q2 2018 in Review
785 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Labcorp (LH) for Q2 2018, worth a combined $17B — up 11% from $15.4B a quarter earlier.
Buyers outnumbered sellers: 62 funds opened new LH positions and 61 closed out — a net gain of 1 holder — while 279 added to existing stakes and 302 trimmed.
The largest buyer was Amundi Asset Management US, adding an estimated $228M. The largest seller was Glenview Capital Management, cutting an estimated $237M.
- 785 institutional investors held Labcorp (LH) as of Q2 2018, down from 791 in Q1 2018.
- Funds reported $17B of Labcorp stock for Q2 2018, up 11% quarter-over-quarter.
- 62 funds opened new Labcorp positions in Q2 2018 and 61 closed out, a net change of +1 holder.
- The largest Labcorp buyer in Q2 2018 was Amundi Asset Management US, an estimated $228M added.
- The largest Labcorp seller in Q2 2018 was Glenview Capital Management, an estimated $237M sold.
Based on aggregated 13F filings for Q2 2018.